Skip to main content

Table 1 Clinical characteristics, blood tests and cardiovascular assessment of patients with type 2 diabetes mellitus (T2DM) and controls

From: Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus

Parameters

T2DM

Controls

P value

 

(n = 100)

(n = 150)

 

Age, years

62±10

60±9

0.20

Female, % (n)

53 (53)

51(77)

0.90

Systolic blood pressure, mmHg

138±19

121±19

<0.01

Diastolic blood pressure, mmHg

77±9

74±9

0.01

Body mass index, kg/m2

25.5±4.2

23.5±3.4

<0.01

Medical history

Current smoker, % (n)

26 (26)

18 (27)

0.16

Hypertension, % (n)

61 (61)

11 (17)

<0.01

Hypercholesterolemia, % (n)

60 (60)

27 (40)

<0.01

Serum lipid profile, renal function and inflammatory marker

Total cholesterol, mmol/L

4.9±0.9

5.1±0.8

0.15

Triglycerides, mmol/L

1.5±0.8

1.3±0.7

0.03

High density lipoprotein, mmol/L

1.4±0.4

1.5±0.4

<0.01

Low density lipoprotein, mmol/L

2.8±0.7

3.0±0.7

0.10

Creatinine, μmol/l

80±23

75±15

0.03

Fasting glucose, mmol/L

7.4±2.1

5.0±0.5

<0.01

HbA1c, %

7.6±1.2

5.9±0.4

<0.01

hs-CRP, mg/L

2.3±5.3

2.3±5.2

0.98

hs-TnI, μg/L

5.7±9.2

3.2±1.9

<0.01

Elevated hs-TnI, %(n)

10 (10)

1 (1)

<0.01

Cardiovascular assessment

   

ba-PWV, ms-1

17.98±3.91

15.70±2.96

<0.01

Brachial FMD, %

2.6±3.5

5.5±4.2

<0.01

Carotid IMT, mm

0.96±0.20

0.86±0.14

<0.01

  1. Abbreviations: ba-PWV brachial ankle pulse wave velocity, FMD flow mediated dilatation, hs-CRP high sensitivity C-reactive protein, hs-TnI high sensitivity Troponin I, IMT intima media thickness.